Clinical Trials
2 trialsNCT00326131 2010-03-02
A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer
Bristol-Myers Squibb
Phase 1 Terminated
NCT00332748 2010-03-02
A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
Bristol-Myers Squibb
Phase 1 Terminated